Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

6 May 2025 15:00

RNS Number : 5428H
Computacenter PLC
06 May 2025
 

 

 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

Computacenter plc

(the 'Company')

 

 

The following notification is made under article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by a Director and Person Discharging Managerial Responsibilities ('PDMR') of the Company.

 

The Company announces that its Chief Executive Officer, Mr Michael John Norris, sold 117,223 shares, on 1 May 2025. Following the sale Mr Norris retains 1,079,214 shares, including those held by a PCA.

 

The relevant FCA transaction notification can be found below.

 

PDMR/PCA FCA Transaction Notification

 

 

1.

 

 

Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Michael John Norris

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Chief Executive Officer

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Ordinary Shares acquired following exercise of a nil-cost option awarded under the Computacenter Performance Share Plan 2005 (the 'PSP Award'). There was no price payable on the grant or exercise of the PSP Award. Vesting of the PSP Award was subject to the achievement of a performance condition over a three-year period and released after a two-year holding period.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

Nil

 

110,977

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

Nil

 

 

 

110,977

 

4(e)

 

 

Date of the transaction

 

 

01-05-2025

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue. The Ordinary Shares for the above-mentioned exercise were satisfied out of those held by the 2011 Computacenter Employee Benefit Trust.

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

Sale of Ordinary Shares. Sold 110,977 shares acquired following the exercise of a nil-cost option vested and dividend equivalent 6,246 shares acquired under the Computacenter Performance Share Plan 2005.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

24.6839

 

117,223

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

24.6839

 

 

 

117,223

 

4(e)

 

 

Date of the transaction

 

 

01-05-2025

 

 

4(f)

 

 

Place of the transaction

 

 

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADSKELASEFA
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.